Eisai Future Growth
Future criteria checks 2/6
Eisai is forecast to grow earnings and revenue by 15.8% and 3.3% per annum respectively. EPS is expected to grow by 15.8% per annum. Return on equity is forecast to be 8.8% in 3 years.
Key information
15.8%
Earnings growth rate
15.8%
EPS growth rate
Pharmaceuticals earnings growth | 12.7% |
Revenue growth rate | 3.3% |
Future return on equity | 8.8% |
Analyst coverage | Good |
Last updated | 07 May 2024 |
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2027 | 832,894 | 82,662 | 93,168 | 143,877 | 7 |
3/31/2026 | 868,202 | 73,232 | 55,212 | 93,862 | 13 |
3/31/2025 | 781,159 | 50,022 | 43,734 | 81,902 | 14 |
3/31/2024 | 738,700 | 41,993 | 72,396 | 99,568 | 14 |
12/31/2023 | 749,460 | 45,421 | 35,701 | 61,925 | N/A |
9/30/2023 | 759,329 | 48,096 | 20,569 | 46,335 | N/A |
6/30/2023 | 757,075 | 48,874 | -20,313 | 6,924 | N/A |
3/31/2023 | 744,402 | 55,432 | -36,331 | -1,772 | N/A |
12/31/2022 | 737,098 | 26,705 | -17,149 | 18,648 | N/A |
9/30/2022 | 752,500 | 32,233 | -8,913 | 30,329 | N/A |
6/30/2022 | 741,594 | 32,690 | 94,326 | 135,806 | N/A |
3/31/2022 | 756,226 | 47,954 | 77,123 | 117,590 | N/A |
12/31/2021 | 712,935 | 57,311 | 85,128 | 124,927 | N/A |
9/30/2021 | 691,250 | 62,508 | 80,215 | 123,618 | N/A |
6/30/2021 | 679,253 | 59,855 | 8,589 | 49,533 | N/A |
3/31/2021 | 645,942 | 42,119 | 35,709 | 73,853 | N/A |
12/31/2020 | 707,888 | 93,682 | 52,352 | 95,670 | N/A |
9/30/2020 | 713,400 | 120,571 | 77,080 | 112,990 | N/A |
6/30/2020 | 707,203 | 124,523 | 81,101 | 116,904 | N/A |
3/31/2020 | 695,621 | 121,767 | 52,556 | 102,782 | N/A |
12/31/2019 | 661,646 | 96,659 | 21,665 | 72,461 | N/A |
9/30/2019 | 631,974 | 57,725 | 12,273 | 62,240 | N/A |
6/30/2019 | 643,531 | 72,747 | 38,725 | 87,299 | N/A |
3/31/2019 | 642,834 | 63,386 | 76,092 | 103,714 | N/A |
12/31/2018 | 627,367 | 63,714 | 151,104 | 171,330 | N/A |
9/30/2018 | 625,106 | 65,679 | 167,298 | 186,973 | N/A |
6/30/2018 | 611,499 | 54,347 | 145,007 | 165,689 | N/A |
3/31/2018 | 600,054 | 51,845 | 124,916 | 149,649 | N/A |
12/31/2017 | 569,814 | 29,048 | 42,233 | 72,041 | N/A |
9/30/2017 | 554,276 | 30,269 | N/A | 61,644 | N/A |
6/30/2017 | 544,027 | 29,425 | N/A | 76,929 | N/A |
3/31/2017 | 539,097 | 39,358 | N/A | 75,851 | N/A |
12/31/2016 | 530,696 | 55,031 | N/A | 76,725 | N/A |
9/30/2016 | 542,313 | 71,812 | N/A | 78,627 | N/A |
6/30/2016 | 545,602 | 69,227 | N/A | 69,710 | N/A |
3/31/2016 | 547,922 | 54,933 | N/A | 95,617 | N/A |
12/31/2015 | 566,435 | 44,886 | N/A | 96,347 | N/A |
9/30/2015 | 554,912 | 43,871 | N/A | 82,653 | N/A |
6/30/2015 | 554,885 | 43,021 | N/A | 89,212 | N/A |
3/31/2015 | 548,465 | 43,254 | N/A | 76,022 | N/A |
12/31/2014 | 560,795 | 40,152 | N/A | 67,972 | N/A |
9/30/2014 | 561,938 | 15,717 | N/A | 81,637 | N/A |
6/30/2014 | 578,945 | 29,225 | N/A | 81,339 | N/A |
3/31/2014 | 600,363 | 32,955 | N/A | 85,687 | N/A |
12/31/2013 | 590,152 | 43,756 | N/A | 78,597 | N/A |
9/30/2013 | 592,679 | 51,447 | N/A | 77,521 | N/A |
6/30/2013 | 580,997 | 45,811 | N/A | 57,212 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 4523's forecast earnings growth (15.8% per year) is above the savings rate (0.2%).
Earnings vs Market: 4523's earnings (15.8% per year) are forecast to grow faster than the JP market (9.5% per year).
High Growth Earnings: 4523's earnings are forecast to grow, but not significantly.
Revenue vs Market: 4523's revenue (3.3% per year) is forecast to grow slower than the JP market (4.4% per year).
High Growth Revenue: 4523's revenue (3.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 4523's Return on Equity is forecast to be low in 3 years time (8.8%).